Blog - Page 2906 of 5594

WednesdayJun 19, 2013 8:25 am

CE Mark Approval Granted for Chembio Diagnostics, Inc. (CEMI) SURE CHECK HIV 1/2 Assay for Rapid Point-of-Care Detection of HIV

Point-of-care (POC) diagnostics test leader Chembio Diagnostics announced that European regulators have granted CE Mark approval for the company’s SURE CHECK HIV 1/2 Assay. Now cleared for commercialization within the European Union for rapid, point-of-care detection of HIV, the SURE CHECK HIV 1/2 Assay is also FDA approved and is being distributed in the United States by Alere NA as Clearview COMPLETE HIV 1/2. Currently, Chembio is working with commercialization partners in Europe and anticipates sales of the SURE CHECK HIV 1/2 Assay in the E.U. by Q1 of 2014. In France alone, the administration of 5.2 million HIV tests…

WednesdayJun 19, 2013 8:19 am

Doug Stovall Appointed as COO of Augme Technologies, Inc. (AUGT) and Subsidiary

Yesterday, Augme Technologies and its wholly-owned subsidiary, Hipcricket®, announced Doug Stovall’s appointment as Chief Operating Officer of both companies. "I'm excited to take on this new role and work with Ivan even closer in taking our leading mobile engagement company to new heights," Stovall remarked. "My passion for mobile is rooted in a belief that the mobile device will be the personal gateway to all of the information that individuals will need or desire and that brands will respond with significant marketing dollars, growing our industry substantially. Our company will be there to capitalize on that opportunity." Mr. Stovall joined…

TuesdayJun 18, 2013 4:34 pm

International Stem Cell Corp. (ISCO) Stem Cell Technology a Game Changer for Regenerative Medicine

International Stem Cell Corp. is focused on treating diseases of the eye, nervous system, and liver by utilizing a new stem cell technology called parthenogenesis. The regenerative technology uses unfertilized eggs, sidestepping the controversial use of embryo stem cells, to address immune-rejection. Stem cells not only have the ability to proliferate, but also to change (differentiate) into more specialized cells such as skin, liver, or blood cells. Because these “pluripotent” stem cells have the potential to become any cell in the body, they are considered the most powerful stem cells. The first type of pluripotent stem cells to be studied…

TuesdayJun 18, 2013 3:59 pm

Tungsten Corp. (TUNG) High Concentration Tungsten Anomalies Detected at Cherry Creek in Nevada

Tungsten Corp., the domestically focused tungsten developer which has put together a nice land package between their 2.3k-acre Cherry Creek property in Nevada and a second project in Idaho, at the historically-producing Wildhorse Mine property, reported today that analysis of the most recent survey data on Cherry Creek has kicked up a bunch of new, heavily-mineralized areas. A battery of rock, soil, and stream sediment sampling from the last work phase, parsed by Carlin Trend Mining Services Ltd., over in Elko, shows several targets with high concentrations of tungsten mineralization, and the company is already raring to go for another…

TuesdayJun 18, 2013 2:16 pm

GRILLiT, Inc. (GRLT) is “One to Watch”

GRILLiT was founded on the concept of delivering a fast-casual dining experience with fresh, nutritious home-style cooking. Leveraging more than four decades of experience in the food industry, the founders of GRILLiT established this unique business model to satisfy the ever-increasing demand for delicious and healthy food while providing the perfect ambiance for guest to relax and enjoy great cuisine. The company sources its ingredients from local and domestic farmers to ensure crisp, fresh produce and grain-fed Angus beef. The cooking techniques and low-sodium recipes employed result in uniquely healthy and delectable meal choices. Using the best possible ingredients, GRILLiT…

TuesdayJun 18, 2013 2:16 pm

GRILLiT, Inc. (GRLT) is "One to Watch"

TuesdayJun 18, 2013 11:58 am

Noble Roman Inc. (NROM) Continues Expansion Efforts of Take’N’Bake Concept

Indianapolis based franchisor of Noble Roman's Pizza and Tuscano's Italian Style Subs, Noble Roman, provided an update today on the continued expansion of its popular take-n-bake (TNB). The expansion currently targets grocery stores around the country as well as market growth of its stand-alone take-n-bake franchises. The company has signed five new stand-alone TNB franchise agreements in the last two weeks alone, bringing the total number of take-n-bake franchises open or currently in development to 16 total. Of those, seven are currently in operation and open; the other nine are under construction and have tentative openings scheduled during the next…

TuesdayJun 18, 2013 11:54 am

Follow QualityStocks on Twitter!

The equity markets are constantly moving and it is imperative that an active trader can find out what is happening in real-time. Even if you aren’t trading all day long – it is important to stay on top of the latest-breaking news. That is why we created our Twitter account just for you. By following us at Twitter, you will be right on top of the action in the micro-cap and small-cap markets. You will receive short alerts regarding stock movements, news releases, and our new “Ones to Watch.” Every week we send dozens of tweets to bring our followers…

TuesdayJun 18, 2013 11:39 am

Cardium Therapeutics, Inc. (CXM) Builds Diverse Portfolio with Broad Commercialization Opportunities

It’s not something you’d expect to find in a regenerative medicine company’s portfolio, but Cardium Therapeutics’ To Go Brands healthy nutraceutical supplement business is complementary to the company’s overarching mission of meeting unmet medical needs as part of an individual’s overall health and wellness. Cardium in October 2012 acquired the assets, business, and product portfolio of To Go Brands, which develops and markets more than 25 products including nutraceutical powder mixes, supplements, and chews to support healthy lifestyles. The brand’s Healthy To Go product line offers a host of healthy product offerings distributed through mass food and drug channels at…

TuesdayJun 18, 2013 10:44 am

Registered Direct Offering of $12.0 Million Completed by Elephant Talk Communications Corp. (ETAK)

Yesterday, Elephant Talk Communications Corp. announced the completion of a registered direct public offering of an aggregate $12.0 million, which was led by a $4.5 million investment from company CEO Steven van der Velden, a $5.0 million investment from Crede CG III Ltd. (a wholly owned subsidiary of Crede Capital Group LLC) and investors placed by Dawson James Securities to purchase an additional $2.5 million. The company sold an aggregate of 17,425,638 shares of common stock, par value $0.00001 per share, and warrants for purchasing up to an aggregate of 7,841,537 shares of common stock. The shares are being sold…

Site Search

Company Search